Last checked at 25 Sep 2018 17:36
25 September 2018
Animalcare Group plc
("Animalcare", the "Company" or the "Group")
Dividend declaration for the six months ended 30 June 2018
Animalcare Group plc (AIM: ANCR), the pan-European Animal Health business, is pleased to announce that it will pay an interim dividend of 2.0 pence per ordinary share on 23rd November 2018 to shareholders whose names are on the Register of Members at close of business on 26th October 2018. The ordinary shares will become ex-dividend on 25th October 2018.
For further information, please contact:
Animalcare Group plc | Tel: 01904 487 687 |
Chris Cardon, Chief Executive Officer | |
Panmure Gordon (Nominated Adviser & Broker) | Tel: 020 7886 2500 |
Corporate Finance | |
Freddy Crossley / Emma Earl | |
Corporate Broking | |
James Stearns | |
Consilium Strategic Communications | animalcare@consilium-comms.com |
Amber Fennell / Chris Welsh / Hendrik Thys |
About Animalcare (www.animalcaregroup.co.uk)
Animalcare Group plc is a UK AIM listed veterinary sales, marketing and product development company resulting from the merger of Animalcare and Ecuphar NV.
Post-merger Animalcare is a pan-European animal health company, with a broad geographic footprint. The Company now has direct sales in seven countries (UK, Belgium, Netherlands, Spain, Portugal, Italy and Germany) and exports to approximately 50 markets worldwide.
The enlarged Company has nearly 100 sales representatives and 28 agents operating across Europe and owns 50 licensed drugs, eight vaccines and over 100 care and nutraceutical products.
Animalcare invests in developing its own pharmaceutical products, seeks distribution partnerships and product acquisitions.
For more information see Animalcare Ltd (www.animalcare.co.uk) and Ecuphar NV (www.ecuphar.com).